ST8SIA6-AS1 serves as a prognostic biomarker in cancer and exhibits oncogenic properties in prostate cancer

ST8SIA6-AS1, a significant oncogenic lncRNA, could promote disease progression in PCa and could serve as a significant prognostic marker for adverse outcomes in cancer.

Authors

Institutions

Publication Details

Journal
Frontiers in Genetics
Published
2025-11-06
DOI
https://doi.org/10.3389/fgene.2025.1648077
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ST8SIA6-AS1 serves as a prognostic biomarker in cancer and exhibits oncogenic properties in prostate cancer

G. Chen, J Yang, Y-Q. Huang, Shaoxing Zhu et al.
Frontiers in Genetics
Cancer-related molecular mechanisms research
article

ST8SIA6-AS1 serves as a prognostic biomarker in cancer and exhibits oncogenic properties in prostate cancer

G. Chen, J Yang, Y-Q. Huang, Shaoxing Zhu, Yaoan Wen, Shuyuan Zhan, Song Zheng
article en

Abstract

ST8SIA6-AS1, a significant oncogenic lncRNA, could promote disease progression in PCa and could serve as a significant prognostic marker for adverse outcomes in cancer.

Frontiers in GeneticsVol. 16
Fujian Medical University (CN), Longyan University (CN), Union Hospital (CN)
National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, Fujian Medical University
Openalex Percentile: Top 59%
Cancer-related molecular mechanisms research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.